zonisamide has been researched along with Obsessive-Compulsive Disorder in 2 studies
Zonisamide: A benzisoxazole and sulfonamide derivative that acts as a CALCIUM CHANNEL blocker. It is used primarily as an adjunctive antiepileptic agent for the treatment of PARTIAL SEIZURES, with or without secondary generalization.
zonisamide : A 1,2-benzoxazole compound having a sulfamoylmethyl substituent at the 3-position.
Obsessive-Compulsive Disorder: An anxiety disorder characterized by recurrent, persistent obsessions or compulsions. Obsessions are the intrusive ideas, thoughts, or images that are experienced as senseless or repugnant. Compulsions are repetitive and seemingly purposeful behavior which the individual generally recognizes as senseless and from which the individual does not derive pleasure although it may provide a release from tension.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Zonisamide was administered at age 6 years, which was effective against her seizures, but selective mutism, violent behaviour, and lack of concentration developed at age 10 years." | 1.31 | Selective mutism and obsessive compulsive disorders associated with zonisamide. ( Hirai, K; Jozaki, K; Kimiya, S; Kumagai, N; Seki, T; Tabata, K, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirai, K | 1 |
| Kimiya, S | 1 |
| Tabata, K | 1 |
| Seki, T | 1 |
| Jozaki, K | 1 |
| Kumagai, N | 1 |
| Miyamoto, T | 1 |
| Kohsaka, M | 1 |
| Koyama, T | 1 |
2 other studies available for zonisamide and Obsessive-Compulsive Disorder
| Article | Year |
|---|---|
Selective mutism and obsessive compulsive disorders associated with zonisamide.
Topics: Adolescent; Anticonvulsants; Epilepsies, Partial; Female; Humans; Isoxazoles; Male; Mutism; Obsessiv | 2002 |
Psychotic episodes during zonisamide treatment.
Topics: Adult; Age Factors; Anticonvulsants; Case-Control Studies; Child; Epilepsy; Female; Humans; Isoxazol | 2000 |